# US 6,730,790 B2 · Chlorinated heterocyclic compounds and methods of synthesis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,730,790 B2
- Document ID: US6730790B2
- Status: Granted
- Kind: B2
- Application number: 10/281,684
- Filed: 2002-10-28
- Published: 2003-09-04
- Granted: 2004-05-04
- Earliest claimed: 2002-03-01
- Assignees: R.T. Alamo Ventures I, LLC
- Inventors: Stefan Kwiatkowski; Miroslaw Golinski
- Web page: https://patentgrep.com/patent/US6730790B2

## CPC

- C07D 215/36: Sulfur atoms (C07D215/24 takes precedence)
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

Compositions of the present invention comprise chlorinated heterocyclic compounds, including racemic monochloroflosequinan, purified enantiomers of monochloroflosequinan and the sulfone derivative of monochloroflosequinan. The methods of the present invention comprise the synthesis of racemic monochloroflosequinan and derivatives thereof, including the sulfone derivative. Intermediates in the synthesis are also provided. The methods further comprise the synthesis of enantiomers of monochloroflosequinan.

## Claims

### Claim 1

A composition comprising racemic 3-chloromethylsulfinyl-7-fluoro-1-methyl-4-quinolone.

### Claim 2

A composition comprising (S)-(+)-3-chloromethylsulfinyl-7-fluoro-1-methyl-4-quinolone in enantiomeric excess.

### Claim 3 (depends on 2)

A composition according to claim 2, wherein said (S)-(+)-3-chloromethylsulfinyl-7-fluoro-1-methyl-4-quinolone is at least 90% of the enantiomeric excess.

### Claim 4 (depends on 2)

A composition according to claim 2, wherein said (S)-(+)-3-chloromethylsulfinyl-7-fluoro-1-methyl-4-quinolone is at least 95% of the enantiomeric excess.

### Claim 5

A composition comprising (R)-(−)-3-chloromethylsulfinyl-7-fluoro-1-methyl-4-quinolone in enantiomeric excess.

### Claim 6 (depends on 5)

A composition according to claim 5, wherein said (R)-(−)-3-chloromethylsulfinyl-7-fluoro-1-methyl-4-quinolone; is at least 90% of the enantiomeric excess.

### Claim 7 (depends on 5)

A composition according to claim 5, wherein said (R)-(−)-3-chloromethylsulfinyl-7-fluoro-1-methyl-4-quinolone is at least 95% of the enantiomeric excess.

### Claim 8

A composition comprising 3-chloromethylsulfonyl-7-fluoro-1-methyl-4-quinolone.

### Claim 9

A composition comprising 3-chloromethylthio-7-fluoro-1-methyl-4-quinolone.

### Claim 10

A method for the synthesis of chlorodesoxyflosequinan, comprising:
a) providing:
i) flosequinan, and
ii) triphenyl phosphine; and
b) reacting said flosequinan and triphenyl phosphine in an organic solvent under conditions such that desoxyflosequinan (7-fluoro-1-methyl-3-methylthio-4-quinolone) is produced; and
c) further reacting said desoxyflosequinan with N-chlorosuccinimide and 2,2′-azobisisobutyronitrile in an organic solvent under conditions such that chlorodesoxyflosequinan (3-chloromethylthio-7-fluoro-1-methyl-4-quinolone) is produced.

### Claim 11 (depends on 10)

The method of claim 10, wherein said organic solvent in said reacting step b) is selected from the group consisting of carbon tetrachloride, xylene and toluene.

### Claim 12 (depends on 10)

The method of claim 10, wherein said providing step a) optionally provides iii) a catalyst, and said reacting step b) occurs in the presence of said catalyst.

### Claim 13 (depends on 12)

The method of claim 12, wherein said organic solvent in said reacting step b) is selected from the group consisting of xylene and toluene.

### Claim 14 (depends on 12)

The method of claim 12, wherein said catalyst is tetrabromomethane.

### Claim 15 (depends on 10)

The method of claim 10, wherein said organic solvent in step c) is selected from the group consisting of carbon tetrachloride and benzene.

### Claim 16

A method for the synthesis of chlorodesoxyflosequinan, comprising:
a) providing:
i) flosequinan,
ii) thionyl chloride, and
iii) pyridine; and
b) reacting said flosequinan, thionyl chloride and pyridine in an organic solvent under conditions such that chlorodesoxyflosequinan (3-chloromethylthio-7-fluoro-1-methyl-4-quinolone) is produced.

### Claim 17

A method for the synthesis of monochloroflosequinan, comprising:
a) providing:
i) chlorodesoxyflosequinan (3-chloromethylthio-7-fluoro-1-methyl-4-quinolone),
ii) hydrogen peroxide, and
iii) potassium carbonate; and
b) reacting said chlorodesoxyflosequinan, hydrogen peroxide and potassium carbonate in a solvent under conditions such that monochloroflosequinan (3-chloromethylsulfinyl-7-fluoro-1-methyl-4-quinolone) is produced.

### Claim 18

A methods for the synthesis of monochloroflosequinan, comprising:
a) providing:
i) flosequinan, and
ii) N-chlorosuccinimide; and
b) reacting said flosequinan and N-chlorosuccinimide in an organic solvent under conditions such that monochloroflosequinan (3-chloromethylsulfinyl-7-fluoro-1-methyl-4-quinolone) is produced.

### Claim 19 (depends on 18)

The method of claim 18, wherein said organic solvent is selected from the group consisting of carbon tetrachloride and benzene.

### Claim 20 (depends on 19)

The method of claim 19, wherein when said organic solvent is carbon tetrachloride, said reacting step b) additionally includes 2,2′-azobisisobutyronitrile.

### Claim 21

A method for the synthesis of monochloroflosequinan, comprising:
a) providing:
i) chlorodesoxyflosequinan (3-chloromethylthio-7-fluoro-1-methyl-4-quinolone), and
ii) a camphor based reagent; and
b) reacting said chlorodesoxyflosequinan and camphor based reagent in an organic solvent under conditions such that an enantiomer of monochloroflosequinan is produced in enantiomeric excess.

### Claim 22 (depends on 21)

The method of claim 21, wherein said camphor based reagent is (R)-(−)-(10-camphorsulfonyl) oxaziridine.

### Claim 23 (depends on 21)

The method of claim 21, wherein said camphor based reagent is (S)-(+)-(10-camphorsulfonyl) oxaziridine.

### Claim 24 (depends on 22)

The method of claim 22, wherein said enantiomer of monochloroflosequinan is (S)-(+)-3-chloromethylsulfinyl-7-fluoro-1-methyl-4-quinolone.

### Claim 25 (depends on 23)

The method of claim 23, wherein said enantiomer of monochloroflosequinan is (R)-(−)-3-chloromethylsulfinyl-7-fluoro-1-methyl-4-quinolone.

### Claim 26

A method for the synthesis of Monochloroflosequinan sulfone, comprising:
a) providing:
i) monochloroflosequinan (3-chloromethylsulfinyl-7-fluoro-1-methyl-4-quinolone), and
ii) m-chloroperoxybenzoic acid; and
b) reacting said monochloroflosequinan and m-chloroperoxybenzoic acid in an organic solvent under conditions such that monochloroflosequinan sulfone (3-chloromethylsulfonyl-7-fluoro-1-methyl-4-quinolone) is produced.
